Effect of peroxisome proliferator-activated receptor-α agonist (bezafibrate) on gastric secretion and gastric cytoprotection in rats

Fundamental and Clinical Pharmacology

Volumn 21, Issue 3, 2007, Pages 291-296

  Pathak, Rahul ^a   Asad, Mohammed ^a   Jagannath Hrishikeshavan, H ^a   Prasad, Satya ^b  

^a KRUPANIDHI COLLEGE OF PHARMACY   (India)

^b MNR Medical College   (India)

Author keywords

Bezafibrate; Gastric cytoprotection; Gastric secretion; Gastric ulcer; PPAR receptor

Indexed keywords

ACETIC ACID; ALCOHOL; BEZAFIBRATE; INDOMETACIN; MISOPROSTOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; RANITIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; INTESTINE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STOMACH ANTRUM; STOMACH EPITHELIUM; STOMACH PROTECTION; STOMACH SECRETION; STOMACH ULCER; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCER HEALING; ULCEROGENESIS;

ACETIC ACID; ANIMALS; ANTI-ULCER AGENTS; BEZAFIBRATE; ETHANOL; GASTRIC ACID; GASTRIC MUCOSA; INDOMETHACIN; MALE; MUCUS; PPAR ALPHA; RATS; RATS, WISTAR; REPERFUSION INJURY; STOMACH ULCER;

EID: 34249089795     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00475.x     Document Type: Article

References (35)

1. Kaunitz J.D., Akiba Y. Gastroduodenal mucosal defense: role of endogenous mediators. Curr. Opin. Gastroenterol. (2004) 20 526 532.
2. Noble P.J.M., Wilde G., White M.R.H. et al. Stimulation of gastrin-CCKB receptor promotes migration of gastric AGS cells via multiple paracrine pathways. Am. J. Physiol. Gastrointest. Liver Physiol. (2003) 284 75 84.
3. Suzuki H., Masaoka T., Miyazawa M., Suzuki M., Miura S., Ishii H. Gastric mucosal response to Helicobacter pylori. Keio. J. Med. (2002) 51 (Suppl. 2) 40 44.
4. Wallace J.L., Zamuner S.R., McKnight W. et al. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. (2004) 286 76 81.
5. Konturek P.C., Brzozowski T., Kania J. et al. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/reperfusion in rat. Scand. J. Gastroenterol. (2003) 38 468 476.
6. Lachal S., Ford J., Shulkes A., Baldwin G.S. PPARalpha agonists stimulate progastrin production in human colorectal carcinoma cells. Regul. Pept. (2004) 120 243 251.
7. Martinsen T.C., Skogaker N.E., Bendheim M.O., Waldum H.L. Antral G cells in rats during dosing with a PPAR alpha agonist: a morphometric and immunocytochemical study. Med. Electron Microsc. (2003) 36 18 32.
8. Allen A., Flemstrom G., Garner A., Kivilaakso E. Gastroduodenal mucosal protection. Physiol. Rev. (1993) 73 823 857.
9. Newaz M., Blanton A., Fidelis P., Oyekan A. NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects. Mutat. Res. (2005) 579 163 171.
10. Mori Y., Oana F., Matsuzawa A., Akahane S., Tajima N. Short-term effect of bezafibrate on the expression of adiponectin mRNA in the adipose tissues: a study in spontaneously type 2 diabetic rats with visceral obesity. Endocrine (2004) 25 247 251.
11. Asad M., Shewade D.G., Koumaravelou K., Abraham B.K., Vasu S., Ramaswamy S. Gastric anti-secretory antiulcer activity of oxytocin in rats and guineapigs. Life Sci. (2001) 70 17 24.
12. Lacy E.R., Hund P., Tietge J. Effects of misoprostol, cimetidine and ethanol on rat gastric plasma volume and morphology. J. Clin. Gastroenterol. (1990) 12 158 169.
13. Okabe S., Pfeiffer C.J., Roth J.L. Experimental production of duodenal and antral ulcers in rats. Fed. Proc. (1970) 29 255.
14. Khan H.A. Computer assisted visualization and quantitation of experimental gastric lesions in rats. J. Pharmacol. Toxicol. Methods (2004) 49 89 95.
15. Ganguly A.K. A method for quantitative assessment of experimentally produced ulcers in stomach of rats. Experientia (1969) 25 1124.
16. Shay H., Komarov S.A., Fele S.S., Meranze D., Gruenstein H., Siplet H. A simple method for uniform production of gastric ulceration in rat. Gastroenterology (1945) 5 43 61.
17. Kulkarni S.K. Hand book of experimental pharmacology, 3rd edn, Vallabh Prakashan, New Delhi, 1999, pp. 148 150.
18. Hawk P.B., Oser B.L., Summerson H.W. Practical physiological chemistry, 12th edn. Churchill, London, 1947, p. 347.
19. Debnath P.K., Gode K.O., Govinda D.D., Sanyal A.K. Effect of propranolol on gastric secretion in rats. Br. J. Pharmacol. (1974) 51 213 216.
20. Goel R.K., Govinda D.D., Sanyal A.K. Effect of vegetable banana powder on changes induced by ulcerogenic agents in dissolved mucosubstances of gastric juice. Indian J. Gastroenterol. (1985) 4 249.
21. Lowry C.H., Rose borough N.I., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. (1951) 193 265 275.
22. Brzozowski T., Konturek S.J., Kwiecien S. et al. Involvement of endogenous cholecystokinin and somatostatin in gastro protection induced by intra duodenal fat. J. Clin. Gastroenterol. (1998) 27 125 137.
23. DiJoseph J.H., Eash J.R., Mir G.N. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity. J. Pharmacol. Exp. Ther. (1987) 241 97 102.
24. Abdurrahman O., Zeki K., Cihat G., Dogan K., Kader C. The effects of alopurinol on stomach mucosal barrier of rats subjected to ischemia-reperfusion. Turk. J. Med. Sci. (2000) 30 449 451.
25. Okabe S., Roth J.L.A., Pfeiffer C.J. Differential healing periods of the acetic acid ulcer model in rats and cats. Experientia (1971) 27 146 148.
26. Parmar N.S., Desai J.K. A review of the current methodology for the evaluation of gastric and duodenal anti ulcer agents. Indian J. Pharmacol. (1993) 25 120 135.
27. Soll A.H. Pathogenesis of peptic ulcers and implication for therapy. N. Engl J. Med. (1990) 322 909 916.
28. Surendra S. Evaluation of gastric anti-ulcer activity of fixed oil of tulsi and possible mechanism. Indian J. Exp. Biol. (1999) 36 253 257.
29. Vedavyasa S. Gastric mucosal cellular changes induced by indomethacin in male albino rats. Indian J. Exp. Biol. (1999) 37 365 369.
30. Desideri G., Croce G., Tucci M. et al. Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments. J. Clin. Endocrinol. Metab. (2003) 88 5341 5347.
31. Crawford J.M. The gastrointestinal tract, in : Cotran X., Kumar X., Collins X. (Eds Robbins pathologic basis of disease, Saunders, New Delhi, 2003, pp. 787 802.
32. Bregonzio C., Armando I., Ando H., Jezova M., Baiardi G., Saavedra J.M. Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am. J. Physiol. Gastrointest. Liver Physiol. (2003) 285 414 423.
33. Elliott S.N., Wallace J.L. Nitric oxide: a regulator of mucosal defense and injury. J. Gastroenterol. (1998) 33 792 803 A., Redéen S., Grenegård M, Ericson A.C., Sjöstrand S.E. Nitric oxide inhibits gastric acid secretion by increasing intraparietal cell levels of cGMP in isolated human gastric glands. Am. J. Physiol. Gastrointest. Liver Physiol. (2005) 289 1061 1066.
34. Rao S.P., Sathiamoorthy A., Sathiamoorthy S.S. Effect of angiotensin converting enzyme inhibitor (captopril) on gastric ulcer production in pylorus ligated rats. Indian J. Physiol. Pharmacol. (1995) 39 296 298.
35. Uluoglu C., Guney Z., Kilinc M., Bozkurt S., Ercan Z.S. The effects of captopril and naloxone on restraint-cold-stress- and ethanol-induced gastric lesions in rats. Gen. Pharmacol. (1998) 30 701 704.